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xABSTRACT
Steward, Melissa Mary. M.S., Purdue University, December 2012. The Direct Re-
programming of Somatic Cells: Establishment of a Novel System for Photoreceptor
Derivation. Major Professor: Jason S. Meyer.
Photoreceptors are a class of sensory neuronal cells that are deleteriously affected in
many disorders and injuries of the visual system. Significant injury or loss of these
cells often results in a partial or complete loss of vision. While previous studies have
determined many necessary components of the gene regulatory network governing
the establishment, development, and maintenance of these cells, the necessary and
sufficient profile and timecourse of gene expression and/or silencing has yet to be
elucidated. Arduous protocols do exist to derive photoreceptors in vitro utilizing
pluripotent stem cells, but only recently have been able to yield cells that are disease-
and/or patient-specific. The discovery that mammalian somatic cells can be directly
reprogrammed to another terminally-differentiated cell phenotype has inspired an ex-
plosion of research demonstrating the successful genetic direct reprogramming of one
cell type to another, a process which is typically both more timely and efficient than
those used to derive the same cells from pluripotent stem cell sources. Therefore,
the emphasis of this study was to establish a novel system to be used to determine
a minimal transcriptional network capable of directly reprogramming mouse embry-
onic fibroblasts (MEFs) to rod photoreceptors. The tools, assays and experimental
design chosen and established herein were designed and characterized to facilitate
this determination and preliminary data demonstrated the utility of this approach
for accomplishing this aim.
11 INTRODUCTION
The fields of developmental and regenerative biology have long sought to identify novel
approaches for the repair of damaged and/or diseased tissue, including that of the
nervous system. The mammalian central nervous system has been well documented
as one with limited regenerative capabilities, due at least in part to an inhospitable
environment for regeneration [1, 2]. In cases of injury and neurodegeneration, glial
scarring, the lack of proliferating oligodendrocytes, and the presence of inhibitory
factors can physically block or impair the regrowth of damaged neuronal axons and
pathfinding of growth cones [3, 4]. In both injury-induced and neurodegenerative
disorders, a toxic extracellular environment including widespread cell death and a
general absence of growth-promoting signals has been described [4, 5]. The mulitude
of factors contributing to the lack of regeneration in the mammalian central nervous
system has been a significant limitation for the fields of mammalian developmental
biology and regenerative medicine. A further limitation is a reduced ability to study
the molecular mechanisms and sequelae of disease at the cellular level, in both de-
veloping and adult tissue. A lack of animal models for many disorders, as well as
uncharacterized species differences in the pathways involved in injury, neurodegener-
ation and regeneration have hampered efforts to describe the underlying mechanisms
controlling and contributing to these processes.
1.1 Pluripotent stem cells as models and therapeutic agents
When mouse embryonic stem cells (ESCs) were first derived in 1981 [6], followed by
the derivation of human ESCs in 1998 [7], they provided a new model system for
researchers to study developmental and disease processes at a cellular level. At the
2same time, they represented a new potential therapeutic cellular agent for clinicians
as a source for replacement cells in cases of neurodegeneration and injury.
ESCs are derived from the inner cell mass of a fertilized oocyte, and have two defin-
ing characteristics. They are pluripotent, which means that they can give rise to
all the cell types of an adult organism, including all of the specific cell types of the
central nervous system. They are also capable of self-renewal, which allows them to
be cultured and expanded in vitro indefinitely, providing an unlimited source of cells
for applications of research or therapeutics. However, one of the two major limit-
ing attributes of ESCs as applied to the field of therapeutics is the fact that they
are not patient-specific. Thus, these cells have an increased risk of rejection when
transplanted into another individual. A second inherent risk involved with the trans-
plantation of cells derived from a pluripotent cell source is the potential for delivering
pluripotent, or undifferentiated and dividing, cells to the body
The derivation of induced pluripotent stem cells (iPSCs) in 2006 [10] represented
a critical advance for regenerative medicine as the first opportunity to derive cells
from a pluripotent source while circumventing the risk of immune rejection due to
the ability to derive patient-specific lines. These iPSCs provided an opportunity to
derive adult cell types via an indirect cellular reprogramming strategy, which could
serve as the basis for pharmacological screening, disease-modeling and therapeutics
such as cellular replacement or cell rescue enabled by transplantation. However, the
second limiting attribute of ESCs as applied to therapeutics was not overcome with
the advent of this new pluripotent cell source. The delivery of mitotically active,
undifferentiated cells to a niche introduces a risk of tumorogenicity, i.e. tumor for-
mation. Unregulated cell division and invasion of undifferentiated or inappropriately
differentiated cells is a hallmark of certain forms of cancers. The advent of iPSCs
did however, open wide the door for further innovative studies in cellular reprogram-
ming. Directed in vitro differentiation of iPS cells prior to transplantation constitutes
3one mechanism with which to minimize teratogenicity, but it does not exclude the
possibility of even an exceedingly small number of cells avoiding differentiation in
vivo application. An alternate strategy that would eliminate the tetratogenicity of
iPS cell cultures would involve a direct reprogramming strategy. The demonstrated
and replicated ability to genetically reprogram mammalian, adult, somatic cells to a
pluripotent, mitotically-active cellular phenotype stood contrary to the long-standing
tenet of biology that once cells become terminally differentiated, they cannot change
their fate. If adult somatic cells could be genetically reprogrammed to a pluripotent
state and further redifferentiated to specific adult cell phenotypes, the next question
became: could these same adult cells be directly genetically reprogrammed to another
cell fate?
1.2 Seminal studies in cellular reprogramming
Cellular reprogramming experiments conducted over the last 6 decades have laid a
substantial foundation upon which the hypothesis and experimental design of this
study are based. The work of Dr. John Gurdon and Dr. Shinya Yamanaka received
the Noble Prize in Physiology or Medicine in 2012 for their significant and high impact
discoveries in cellular reprogramming. Dr. Gurdon conducted the first experiment
that successfully cloned an organism from a somatic cell source [8]. In this study,
he used the process of somatic cell nuclear transfer (SCNT) established by Briggs
and King [9]. This process involves the transplantation of the nucleus of a somatic
cell to an enucleated, unfertilized oocyte. Cytoplasmic factors in the oocyte were
found to be sufficient to reprogram the somatic nuclei to an effective earlier stage of
development, allowing for the reinitiation of transcription of embryonic genes that
were silenced in the adult cell and initiating cellular division of the oocyte based
upon the genomic DNA of the somatic nucleus. Gurdon exploited this process to
clone a new frog, Xenopus laevis, through the use of a nucleus from a gastrointestinal
cell, removed from an adult frog. Rather than relying on undefined cytoplasmic
4factors within an oocyte, Yamanaka′s work first demonstrated a genetic approach
to reprogram mouse somatic cells to a pluripotent state via lentiviral delivery of a
cocktail of four genes that govern pluripotency [10]. He dubbed the cells derived via
this process induced pluripotent stem cells (iPSCs). Similar to embryonic stem cells,
they were demonstrated to have the capacity to proliferate indefinitely in culture and
differentiate both in vivo and in vitro to cell types derived from all three germ layers -
ectoderm, mesoderm and endoderm. In between the time of these exciting discoveries,
other groups demonstrated the direct reprogramming of fibroblasts to myoblasts via
delivery of a single master transcriptional regulator MyoD [12], as well as the in vivo
direct reprogramming of exocrine cells from the pancreas to insulin-secreting beta
cells [13]. The implication of studies demonstrating these dramatic cell fate changes
was that direct cellular reprogramming of somatic cells was possible utilizing a genetic
approach.
1.3 Advantages of direct reprogramming over indirect reprogramming
There are several advantages afforded by direct reprogramming strategies when com-
pared to those utilizing a pluripotent stem cell intermediary. While either strategy
could be used to yield patient-specific cell populations, those derived via a direct
reprogramming strategy can remain a mitotically inactive cell population. Indirect
reprogramming strategies utilize pluripotent stem cells, which by definition are pro-
liferative and can give rise to more undifferentiated cells, as well cells that are more
differentiated. While in vitro protocols exist to differentiate these stem cells in sub-
stantial numbers and at high efficiencies and cell sorting using surface markers could
purify these cells for many cell types, there remains an increased risk of transplant-
ing undifferentiated cells, that could lead to tumor formation. Upon transplantation,
directly reprogrammed cells would have a much lower risk of tumorigenicity, as the
likelihood of introducing pluripotent stem cells to a new niche is significantly lower.
Another advantage of using direct genetic reprogramming strategies is that they may
5uncover novel genes involved in the gene regulatory network of the desired cell type.
Many indirect reprogramming strategies utilizing in vitro differentiation of pluripo-
tent stem cells to the final cell type involve adding soluble mitogens and growth
factors to the cell culture media to differentiate stem cells, potentially activating or
inactivating often innumerable and overlapping pathways in the cell. Direct genetic
reprogramming strategies allow for the definition of elusive gene regulatory networks
that are ‘necessary and sufficient’ for defined cellular phenotypes that are currently
undescribed. Finally, direct reprogramming strategies are faster, more efficient and
less arduous than those involving a pluripotent intermediary. For example, Marius
Wernig′s group saw 20% conversion rates of fibroblasts to neuronal cells in 2 weeks
time utilizing direct genetic reprogramming [18]. This efficiency, similar to that seen
by many others, is orders of magnitude higher than that seen when establishing
pluripotent stem cell lines, and on the order of weeks instead of months. For pho-
toreceptors specifically, after the pluripotent cell lines are established, it takes up to
another three months to derive photoreceptors from them [19]. None of these advan-
tages conferred by direct genetic reprogramming affect their applicability when com-
pared to cells derived via indirect reprogramming strategies. They can still be used
for studies of development such as cell fate specification and for disease-modeling, as
well as therapeutics such as cell replacement and rescue conferred by transplantation
and also used for drug screening. Not only are none of these applications lost, some
- such as transplantation applications - stand to be enhanced when cell populations
are derived via direct reprogramming.
1.4 Differentiation and direct cellular reprogramming to neural phenotypes
Diseases of and injuries to the central and peripheral nervous system devastate the
sensory experience and motor control of a significant portion of the population each
year. Because of the prevalence and ramifications of these injuries and diseases, many
efforts have focused on the replacement or rescue of neural cell populations once they
6are damaged or lost. In vitro protocols already exist to derive specific neural and
neuronal cell types from pluri- or multi-potent sources such as embryonic stem cells
(ESCs), induced pluripotent stem cells (iPSCs) or neural stem cells [14–17, 19–21].
These protocols are often based upon culturing the stem cells in culture medium with
fetal bovine serum and known proneural soluble growth factors. These factors are
known to be involved in pathways governing neural specification in vivo and induce
expression of neural-specific genes and positive feedback loops leading to the ultimate
differentiation of pluripotent cells to neuronal phenotypes. Until very recently, cells
derived via these protocols provided the best potential source for potential cellular
replacement and rescue strategies, as well as pharmacological screening and disease-
modeling.
The first successful direct, genetic reprogramming of mammalian somatic cells to a
neuronal phenotype was published in 2010 [18] and since that time, many groups
have utilized a similar experimental strategy to derive more specific neuronal cell
types from mammalian somatic sources [22–27]. Vierbuchen et al. first used a strat-
egy similar to the one employed by Yamanaka to derive induced pluripotent stem cells
from fibroblasts [10]. In the landmark studies by Yamanaka group, they sought to
reprogram terminally differentiated, somatic cells to a mitotically active pluripotent
state. Thus, he tested the effects of viral delivery of combinations of transcription
factors known to be active in embryonic stem cells and silenced in quiescent cell popu-
lations. These genes were therefore implicated to be involved in positively regulating
pluripotency. Vierbuchen et al. hypothesized that a similar strategy could be used
to derive neuronal cells directly from fibroblasts [18]. They defined a set of candi-
date transcription factors to test that were known or implicated to be involved in the
processes governing pluripotency or were specific to neural cell populations. They
started with a pool of 19 genes that were virally delivered combinatorially to mouse
embryonic fibroblast (MEF) cells, and screened for neuronal conversion. They ulti-
mately defined a combination of three factors, Brn2, Ascl1 and Myt1l (BAM) that
7could quickly and efficiently convert fibroblasts to neuronal cells. These neuronal cells
were named induced neuronal (iN) cells and importantly were found to express mul-
tiple neural specific proteins, generate action potentials and form functional synapses
when cultured with cortical neuronal or glial cells. These iN cell cultures contained
inhibitory GABA-ergic neuronal cells, excitatory glutaminergic neuronal cells, as well
as some iN cells expressing markers of cortical interneurons and other neuronal sub-
types. Another important discovery from this study was the marked increase in
efficiency and rapidity of neuronal conversion seen using this direct reprogramming
strategy. They reported an approximate 20% conversion efficiency of infected cells
within 2 weeks, wheras traditional methods for iPSC reprogramming typically report
efficiencies of less than 0.1% and require several weeks for effective reprogramming.
This exciting discovery spurred an explosion of studies in the neurosciences employing
to use a similar approach to derive human iN cells, as well as specific neuronal cell
types utilizing the same strategy. By delivering cell-specific transcription factors in
combination with pro-neural genes such as those in the BAM cocktail to somatic cells,
attempts were made to derive dopaminergic neurons or motor neurons, for example.
When the BAM combination of transcription factors was initially delivered to human
cell cultures, immature neuronal phenotypes were reported, along with significant cell
death [23, 24]. It was quickly determined that the addition of another transcription
factor, NeuroD1 to the BAM cocktail resulted in the same neuronal attributes in
human cells after 5-6 weeks as those seen in the mouse system in 2 weeks with the
BAM combinatorial treatment alone. Neural-specific protein expression, action po-
tentials and post-synaptic currents were observed [23]. The differential time-course
of neuronal maturation seen when comparing the mouse and human system in direct
reprogramming is similar to differences seen using mouse and human derived ESCs
and iPSCs and may be reflective of a longer period of maturation during human ges-
tation and in vivo development.
8As dopaminergic neurons are affected in many neurodegenerative disorders, such as
Parkinson′s disease and familial Alzheimer′s disease, replacement or rescue of these
specific neurons holds great promise for strategies of regenerative medicine. Dopamin-
ergic neurons were the first neuronal subtypes to be specified through genetic, di-
rect reprogramming strategies [24–27]. Several independent studies reported different
combinations of factors to derive these action potential-firing, tyrosine-hydroxylase
positive, induced dopaminergic (iDA) cells from human and mouse fibroblast cells,
with efficiencies reported approximating 10% of transduced cells, though only the
delivery of Ascl1, Nurr1 and Lmx1a, or the combination of these 3 genes with Pitx3,
Foxa2 and En1 was capable of reprogramning cells that were characterized to release
dopamine [25, 27]. Spinal motor neurons are another specific neuronal cell type that
is known to be affected by disease-states including spinal muscular atrophy (SMA)
and amyotrophic lateral sclerosis (ALS) or Lou Gehrig′s disease. Less than a month
after reports about the direct reprogramming of human and mouse fibroblasts to in-
duced dopaminergic (iDA) neuronal cells were published, the first study characterized
the direct reprogramming of spinal motor neuronal cells as well [22]. Their highest
efficiencies of conversion (around 5-10% in under 2 weeks) from mouse fibroblasts to
induced motor neuron (iMN) cells were reported using the aforementioned BAM com-
bination with the addition of four spinal motor neuron-specific factors, Lhx3, Hb9,
Isl1 and Ngn2. These iMN cells generated action potentials and responded to both
excitatory and inhibitory neurotransmitters in culture, similar to ESC-derived and
embryonic motor neurons. Addition of NeuroD1 to the pool of these seven factors led
to functional iMN cells reprogrammed from human ESC-derived fibroblasts as well,
that were characterized as similar to their mouse counterparts in the study.
1.5 Specific neuronal subtypes as phenocopies and replacement cell sources
Once defined neuronal cell types could be specified using direct genetic reprogram-
ming, the field was poised to ask if these directly reprogrammed iN cells could 1)
9serve as reliable phenocopies for disease-states, 2) be demonstrated to integrate in
vivo and 3) restore any function that had been lost associated with the particular
disease pathology. Indeed, these questions have been addressed by several studies.
In the first study to derive iMN cells, using both mouse and human cells, iMN cell
sensitivity to growth factor withdrawal was demonstrated similar to embryonic motor
neurons [22]. The significant interest in the factors and pathways that confer neuronal
survival in the context of injury and neurodegenerative disease states makes these cells
a valuable in vitro tool for the study of motor neuron function, survival, disease, in-
jury, and response to exogeneously added or removed defined factors. They further
cocultured their iMN cells with glial cells derived from the SOD1 mutant mouse model
of ALS, as it is known that motor neurons are selectively sensitive to toxic effects of
mutant glia when compared to other neuronal cell types, such as spinal interneu-
rons [28,29]. They indeed demonstrated a reduction in iMN cells to an extent similar
to that seen with ESC-derived motor neurons in this coculture system [28,29]. They
also found that iMNs derived from this mutant mouse model had impaired survival
in culture when compared to wild-type derived iMNs. These findings in combination
suggest that iMNs can serve as phenocopies for “both cell-autonomous and non-cell-
autonomous contributors to motor neuron degeneration in ALS” [22]. Furthermore
this group also used a rigorous test commonly used by the field of neuroscience to
test the in vivo survival, migration ability, and response to in vivo axon guidance
cues of these iMNs, testing their ability to contribute to the developing central ner-
vous system. It was demonstrated that upon injection to the chick embryo neural
tube, iMNs were able to survive in vivo, migrate to appropriate regions to integrate,
and respond appropriately to in vivo axon guidance cues, as demonstrated by their
axonal projections out of the spinal cord via the ventral horn towards the musculature.
Studies of induced dopaminergic (iDA) cells have taken the characterization of the
utility of derived neuronal cells a step farther, demonstrating not only their abil-
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ity to be derived from human patients with diseases such as familial and sporadic
Alzheimer′s [24] or Parkinson′s [25, 27] and exhibit disease-specific phenotypes in
vitro [24] as well as survive and integrate upon transplantation [25, 27]), but also
that upon transplantation iDA cells were able to alleviate symptoms in a mouse
model of Parkinsons disease [27]. Elevated dopamine levels were detected in the
transplanted striatum of 6OHDA lesioned mice compared to controls and eight weeks
after transplantation the animals with implanted cells showed significant reduction
in amphetamine-induced rotation scores when compared to sham-injected or intact
control-lesioned animals. While further studies need conducted aimed to increase the
efficacy of such treatments, this important proof-of-principle establishes the utility
of transplanted iDA cells to restore function in at least one animal model of human
disease or injury.
All of these studies utilized a genetic approach to induce neuronal cells from fibrob-
lasts. While there has been significant overlap in the particular genes or transcription
factors specifically that were delivered, several groups have demonstrated similar cell
phenotypes using various combinations. Interestingly, the group that reprogrammed
fibroblasts from familial and sporadic Alzheimer′s disease patients used a 5-factor
combination of genes to derive their iN cells that included Brn2, Ascl1, Zic1, Olig2
and Myt1l further demonstrating that there are multiple pathways to a neural - even
specific neuronal subtype - identity [24].
1.6 A model that accounts for direct cellular reprogramming
The paradigm of cellular biology during development once stated that cells undergo an
irreversible process of increasing lineage commitment as they undergo differentiation,
i.e. as cells develop and begin to differentiate, they become increasingly committed
to a particular phenotype and once terminally differentiated, they cannot reinitiate
cellular division or change cellular fate. However, an ever-rapidly growing number
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of peer-reviewed studies has indicated and even characterized, events and outcomes
completely contrary to this long-standing tenet of biology. If this relatively new, in-
triguing, expansive body of data cannot be reconciled with the previous biological
model of development and cell fate commitment, then what model does exists to
account for these phenomena that are observed and reproduced in such astounding
numbers?
The gene expression network should be conceptualized as, and has indeed been demon-
strated to be, a highly dynamic, multi-dimensional space. As an accepted rule, mi-
croarray data of global gene expression profiles demonstrates the highly dynamic
nature of gene expression over time, as well as the variability within defined cell
populations. For purposes of modeling, one should imagine each individual gene′s
expression level as represented by an axis [31, 32]. The model depicted and defined
by Huang [32] and Zhou and Huang [31] also describe particular positions within
this multi-dimensional space that are states of gene expression that are low-energy
for the cell to maintain. They name these states “attractor states”. (Figure 1.1)
shows a simplified gene network in which genes X1 and X2 cross-inhibit one another
(a) and in (b) also positively feedback upon themselves. The third panel in each of
these schematics graphically depicts the low energy ‘attractor’ states on the Z-axis of
Quasi-potential [energy] (U) occupied by a cell governed by these feedback networks.
Note that high expression of gene X1 along the y-axis coupled with low expression
of gene X2 on the x-axis is depicted as an attractor state, S1. A similarly stable but
opposite gene expression profile exists at S2, noting a cell
′s state when it has a pattern
of gene expression corresponding to low levels of gene X1 and high levels of gene X2.
As noted in the figure legend, the “higher U is, the less stable that state is [31]”.
The cell reaches a low energy state by occupying a gene expression profile of what
the authors named an ‘attractor state’. Other intermediary gene expression profiles
are less energy efficient, as indicated by their higher position on the Z-axis. The cell
is therefore attracted to these basins of stability that are reflected by cellular pheno-
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types, governed in part by gene expression feedback systems. Direct reprogramming
strategies can therefore be considered two-fold in their approach. They seek to push
the gene expression of a cell far enough out of it′s current attractor state and also
nearest to the attractor state of the cellular phenotype desired.
Figure 1.1. Simplified schematic of gene circuits and attractor states.
Reprinted from Trends in Genetics, 27, Zhou JX, Huang S, Understand-
ing gene circuits at cell-fate branch points for rational cell programming,
pages 55-62, Copyright (2011), with permission from Elsevier. The self-
stimulation (positive feedback) of genes X1 and X2 creates attractor state,
S0, representing a bipotent progenitor that is less stable that (attractor
states) S1 or S2. “The quasi-potential landscape (right panel) offers a view
on the global dynamics by assigning to each point S in the state space a
‘quasi-potential’ U(S) that is inversely related to the approximate relative
stability of S, hence enabling the comparison of the relative ‘depth’ of
attractors or any other point S. In this two-gene system, the state space
is represented by the XY plane, whereas the Z-axis denotes U(S). The
higher U is, the less stable that state is. Thus, the system is attracted to
the lowest points = stable states = attractor states” [31].
Several useful predictions can be made using this model and many have been demon-
strated to be true by the growing body of evidence put forth by studies of indirect
and direct cellular reprogramming. First, since the state or phenotype of a cell at
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any point in time is governed to a large extent by it′s gene expression profile, it is not
permanent, even though relatively stable. If acted upon enough by outside factors
that influence gene expression, a cell′s fate could be changed. This change would be
the result of a significant enough change in gene expression, or enough energy added
to the system, to overcome the stability gained by occupying its current phenotype.
This model also predicts that the processes of cellular reprogramming do not need
to be externally regulated throughout the entire process. Rather, it predicts that
enough of a perturbation in the system can remove the cell from it′s current attrac-
tor state and that upon that perturbation, it will seek the nearest attractor state.
This has been demonstrated by several groups that have used forced gene expression
of lineage- and cell-specific genes to induce the cellular phenotypes they sought to
induce from terminally differentiated cell types that typically have little to no ex-
pression of the specific genes delivered. This model also predicts that cells with more
similar gene expression profiles can more easily be transitioned between. Another
prediction of the model would be that the forced expression of specified genes may
not be necessary. Rather, published by many independent groups, various combina-
tions of genes involved in transcriptional regulation of cell-specific genes could provide
enough change, likely due to positive feedback mechanisms and feed-forward systems
that push gene expression towards a particular, desired attractor state.
1.7 Photoreceptors: A unique opportunity for direct reprogramming
Initial studies establishing direct reprogramming as a viable induction method to de-
rive neuronal cell types were enabled by 1) a need for these specific cell types, as dic-
tated by particularly problematic human disease pathologies and 2) a well-established
body of literature identifying and delineating important gene regulatory networks of
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the final, desired cell types. Photoreceptor cells of the retina constitute an additional
cell type in which both of the requirements also exist, yet direct reprogramming of
somatic cells to a photoreceptor fate has yet to be achieved.
The loss of sight, and the ensuing problems it brings are certainly among our most
basic human fears. Almost 30% of the sensory input to the brain traces back to the
retina, which is commonly referred to as the “window to the brain” [34–36]. The
visual experience begins with photoreceptors, a unique class of neuronal sensory cells
that are responsible for receiving light information that falls on the retina and con-
verting that input to signals that the nervous system can process. The output of pho-
toreceptors is integrated and processed first by interneurons of the retina before the
information is transmitted to visual centers and others in the brain [37]. It should be
no surprise then, that diseases deleteriously affecting photoreceptors are the primary
cause of visual impairment or blindness in most retinal diseases, including macular
degeneration, Lebers congential amaurosis (LCA), and retinal pigmentosa (RP), to
name a few of the more common [36]. Therefore, cellular replacement strategies often
have been aimed at protecting these important sensory cells as well as replacing them
through transplantation, or by stimulating in vivo rescue or replacement by existing
cell populations. Furthermore, studies and models of retinal degeneration could also
provide valuable information about more general features of progressive neurodegen-
eration [38].
Photoreceptors are broadly classified into two main types: cones or rods. Cones
respond to bright light and relay high resolution, color information. Rods on the
other hand, function in low light and are a hundred-fold more light-sensitive than
cones [36, 37, 39]. In mice and humans, 70-80 % of all cells in the neural retina
are photoreceptors, with rods outnumbering cones 30:1 in mice, and 18-20:1 in hu-
mans [36,41,42], indicating that rod photoreceptors are the most abundant cell type
in the retina of both mice and humans. While subtypes of cones exist expressing
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different and singular visual pigments, the mammalian retina has only one rod opsin,
rhodopsin, with a peak sensitivity around 500 nm [36, 37]. Lastly, and importantly,
transplantation studies have demonstrated that rod precursor cells readily incorpo-
rate in the adult retina, differentiate, and form synaptic connections [43]. This study
contrasted these rod progenitors with other progenitor or stem cells from various alter-
nate stages of development that failed to integrate to the same extent as rod progen-
itors [43–47]. For these reasons- abundance, sensitivity, simplicity, and demonstrated
integration- an abundance of research has focused on the gene regulatory networks
of rod photoreceptors. Furthermore, the aforementioned reasons also make rod pho-
toreceptor cells ideal targets for studies of direct cellular reprogramming, as well as
excellent candidates for the first applications of directly reprogrammed cells to regen-
erative medicine, including transplantation experiments aimed at recovering vision
in genetic or injury models where vision has been lost or impaired due to loss of
photoreceptors.
1.8 Transcriptional dominance model of photoreceptor cell fate determination
Decades of research support the transcriptional dominance model (Figure 1.2) of pho-
toreceptor cell fate determination put forth by Dr. Anand Swaroop [36]. While he
states that “the molecular mechanisms that generate photoreceptor precursors from
retinal progenitor cell remain uncharacterized”, several players, including but not
limited to, CrX, Otx2, NrL, Nr2e3 and RORβ have been implicated as necessary in
rod photoreceptor development [36]. Loss of any one of these genes leads to a com-
plete, or almost complete loss of rod photoreceptors, or lack of expression of many
important rod-specific phototransduction genes [36, 48–52]. It should also be noted
that not one of these single genes has been sufficient to induce the differentiation of
rod photoreceptors. However, the demonstrated overlapping targets of these genes, as
well as the step-wise nature of photoreceptor differentiation from retinal progenitors
and the increasingly likely multifactorial and transient nature of the terminal differ-
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entiation process, makes identification of the genes which are necessary and sufficient
a difficult task. So while some hierarchies of gene regulation and feedback loops are
well-established, the ‘necessary and sufficient’ master transcription regulatory net-
work continues to eludes researchers.
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Figure 1.2. “Transcriptional dominance model of photoreceptor cell fate
determination”. Reprinted by permission from Macmillan Publishers Ltd:
Nature Reviews Neuroscience (citation), copyright (2010). “A generic
photoreceptor is formed under the control of homeobox protein OTX2
and other undetermined signals. This precursor is programmed to possess
a ‘default’ S cone state, unless diverted by additional signals” [36].
Lacking this complete information, several groups have been successful in using ESCs
and iPSCs to establish and apply in vitro protocols to derive cells that exhibit defini-
tive properties of photoreceptors both when tested in culture and in transplantation
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studies [14,15,19,20,53,54]. Meyer et al. [19] established a protocol for the derivation
of photoreceptor cells from pluripotent stem cells that capitalized on known stages
of development, and beautifully demonstrated a strong correlation between both the
timecourse and gene and protein expression profiles of characteristic markers between
their in vitro derived cells and normal in vivo development. This indirect reprogram-
ming utilizing iPSCs demonstrated important proof-of-principle that photoreceptor
cells can be derived in vitro and has since served as a standard in the field for the
derivation of these cells [55,56].
Direct reprogramming protocols however, have been much less arduous than those
used to first establish iPSCs and then further differentiate them to the desired somatic
cell type. Because a wealth of information exists about the underlying gene regulatory
network governing photoreceptor development, photoreceptors are highly suited for
direct reprogramming. Thus, efforts described within this thesis sought to capitalize
on established systems and unique models in the fields of photoreceptor development
and direct cellular reprogramming, with aims to establish approaches leading to the
direct differentiation of rod photoreceptors from somatic cells.
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2 ESTABLISHMENT OF A NOVEL SYSTEM FOR DERIVATION OF
PHOTORECEPTORS VIA DIRECT REPROGRAMMING
The work herein described is aimed to design, characterize, establish and provide pre-
liminary results on a system aimed at testing the hypothesis that somatic cells can be
directly reprogrammed to a rod photoreceptor fate in vitro. The overall experimental
aims include: the determination of candidate genes for reprogramming, cloning of
these candidate genes into appropriate vectors, adaptation of a lentivirus system for
gene delivery, generation of cells to use as a high-throughput screening-system for
analysis of virally-infected or transfected somatic cells, providing proof-of-principle
that these constructs lead to induction of gene and protein expression, collection
of preliminary data demonstrating neuralization of somatic cells induced by combi-
nations of known pro-neural genes, and finally, the induction of photoreceptor-like
phenotypes in somatic cells.
2.1 Selection of candidate genes
While many of the genes and proteins involved in photoreceptor development and
maintenance have been identified and are well-characterized, a relatively blind ap-
proach was undertaken to identify known and potentially novel transcription factors
that govern these processes. Briefly, a list of candidate transcription factors was
determined using published microarray datasets specific to early- and late-born rod
photoreceptors.
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Figure 2.1. NRL promoter drives GFP-expression in rod, but not cone,
photoreceptor cells in the retina. Copyright (2006) National Academy of
Sciences, U.S.A. [57]. This figure is reprinted with permission from PNAS.
(A) shows the specificity of GFP-NRL to the outer nuclear layer (ONL) of
the entire adult retina in the GFP-NRL knock-in mouse. (B) demonstrates
that not all cells in the ONL express GFP. (C, D, E) show immunolabelling
with the rhodopsin antibody (red-D) completely overlaps (E) with GFP
expression (C). (F, H, J) GFP expressing cells (F) show no overlap (J) with
cells expressing the cone-specific marker, peanut agglutinin (H). (G, I, K)
Photoreceptor cells are indicated by arrowheads, and cells expressing the
cone-specific marker arrestin (red) shows no overlap with GFP-expressing
(green) cells (K). This figure in sum demonstrates the specificity of NrL-
promoter driven GFP-expression to rod photoreceptors in the retina [57].
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Nrl is a basic motif-leucine zipper transcription factor that is specifically expressed
in rod photoreceptors (Figure 2.1) [57, 66, 67]. Deletion of Nrl in mice results in a
cone-only phenotype in the retina [51,57,68]. Interactions of Nrl with Crx and Nr2e3,
along with other proteins, coordinate the expression of rod-specific genes [57–65] and
down-regulate cone-specific gene expression [63,64,69,70].
Microarray datasets utilizing FACS-sorted rod photoreceptors, enabled by a GFP-
reporter construct under control of the Nrl -promoter, provided gene expression pro-
files at varying developmental time points [57]. Embryonic day 16 (E16) and post-
natal day 2 (P2) were the earliest datasets collected, broadly reflecting genes expressed
in early- and late-born rods, respectively [36, 42, 57, 71]. These datasets (GSE4051:
GSM92633-36, and GSM92641-44, n=4) were then mined for transcription factors
as identified by the RIKEN mouse library, yielding the following preliminary list of
candidate transcription factors (Table 2.1).
Table 2.1
Number of transcription factors determined from data-mining listed by
criteria
E16 P2 50% or more probes All probes
Present Present 494 222
Absent Present 34 15
Present Absent 148 71
Total transcription factors present 676 308
Data-mining of the E16 and P2 microarray data sets [57] yielded the above lists of
transcription factor probes that were present or absent at each timepoint in 50% or
more, or in all probes surveyed. For example, the first line is explained as 50% or
more probes identified 494 transcription factors ‘present’ in the E16 as well as the P2
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datasets. Of these 494 transcription factors, all probes identified 222 transcription
factors ‘present’ in the E16 as well as the P2 dataset. In contrast, the second line is
read as 34 transcription factors were identified as present by 50% of probes in the P2
dataset, but absent in the E16 dataset. Of these 34 transcription factors, 15 of them
were found present in the P2 dataset but absent in the E16 date set using all probes.
The total of 676 genes identified by 50% or more probes were further investigated.
Mouse transcription factors were downloaded from RIKEN Mouse Transcription Fac-
tor Database.
A total of 676 transcription factors were identified as being expressed at either or both
timepoints in 50% or more probes. This list was further narrowed by eliminating
redundancy and cross-referencing published literature on each transcription factor
identified to determine its potential role in governing photoreceptor development or
direct reprogramming. The following criteria were used to identify candidates from
the narrowed list of transcription factors: genes that are known to be 1) specifically
expressed in neural tissue, 2) important for neural development, 3) implicated in
epigenetic remodeling, 4) specifically expressed in the retina, and/or 5) important in
retinal development. Using these specific criteria, 23 candidate genes were identified
for their potential role in photoreceptor reprogramming (Table 2.2). Importantly,
this search revealed many expected transcription factors as established by previous
studies on rod photoreceptor differentiation and maintenance (e.g. Crx, Nrl), but
also some novel candidates as well (e.g. Blimp1, Sp4 ).
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Table 2.2
The list of 23 candidate genes and accession numbers, with their corre-
sponding length in nucleotides
Candidate genes Accession Number Length in nucleotides
ASCL1 CCDS24101.1 696
BLIMP1 NM007548.3 2651
BMI1 BC056384.1 974
BRN2 CCDS18005.1 1338
CRX NM007770.4 972
CTCF BC049131.1 2211
DACH1 BC141130 2100
HDAC1 NM008228 1449
LHX2 BC055741.1 1221
MYBBP1A BC052889.1 4035
MYT1 BC063252.1 3384
NEUROD1 NM010894.2 1074
NEUROD4 BC054391.1 993
NEUROGENIN2 BC055743.1 792
NR2E3 BC017521.1 1188
NRL BC031440.1 714
OLIG2 BC051967.1 972
OTX2 BC017609.1 870
RAX CCDS29311.1 1029
RORβ BC024842.1 1344
SIX6 NM011384.4 741
SP4 NM011384.4 2349
ZIC1 BC060247.1 1344
Total gene basepairs cloned 34255
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2.2 Establishment of a screening system for candidate genes
As a combinatorial approach utilizing a pool of 23 factors would yield a nearly insur-
mountable set of data to analyze given the number of combinations of a set number of
transcription factors that can be designed, it was important to establish a screening
system to narrow the pool of potential candidates with a high-throughput, efficient
approach. As discussed previously, the initial studies demonstrating direct reprogram-
ming used mouse embryonic fibroblasts (MEFs), in part due to their demonstrated
high efficiencies in iPSC reprogramming [10]. For the purposes of reprogramming to
rod photoreceptors, MEFs were derived from mice that have a Rhodopsin-GFP fusion
knock-in as a replacement for native rhodopsin [33]. Since rhodopsin is specifically
expressed in rod photoreceptor cells (Figure 2.2A) [33], MEFs derived from these
animals will express the GFP-fusion protein only when they express the rod-specific
gene, Rhodopsin. These MEF cells were used for experiments testing the ability of
the 23 candidate transcription factors to induce expression of Rhodopsin-GFP (Fig-
ure 2.2B). Because Opsin gene expression is one of the final stages in photoreceptor
differentiation [36], a GFP signal from these cells in culture can serve as a reliable
screening tool for the conversion of fibroblasts to a rod photoreceptor identity.
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Figure 2.2. Specificity of Rhodopsin-GFP fusion to rod photorecep-
tor cells and schematic of experimental design utilizing MEFs derived
from rhodopsin-GFP mice. (A) Retinal sections from 3-week-old mice
expressing the rhodopsin-GFP fusion protein demonstrate left to right
the expression of the GFP in rod photoreceptor outer segments in the
outer nuclear layer (ONL), DAPI-labeled nuclei of the ONL (blue), rho-
damine peanut aggluttin staining of cone sheaths (red), and a merge im-
age demonstrating no overlap of GFP-expression with rhodamine-labeled
cells [33]. Copyright (2004) National Academy of Sciences, U.S.A. [33].
Figure A is reprinted with permission from PNAS. (B) Experimental
schematic adapted from [18] delineating the usage of MEF cells derived
from Rhodopsin-GFP fusion knock-in mice to screen candidate transcrip-
tion factors for their ability to directly reprogram fibroblasts to rod pho-
toreceptor cells.Figure B was adapted by permission from Macmillan Pub-
lishers Ltd: Nature [18], copyright (2010).
2.3 Lentiviral expression construct modifications
A third-generation lentivirus system, utilizing a modified pCSCIGW vector as the
transfer vector, was used for cloning of candidate genes and subsequent virus pro-
duction.These plasmids were generously provided by Dr. Scott Witting, from the
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Indiana University School of Medicine. The expression construct originally contained
a cytomegalovirus (CMV) promoter and an IRES-GFP reporter sequence following
the gene of interest (Figure 2.3).
Figure 2.3. The modification and confirmation of the viral expression con-
struct. The original viral expression plasmid map, pCSCIGW, provided
by Dr. Scott Witting of Indiana University School of Medicine
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Published data suggested that a more appropriate promoter for these applications
would be that of phosphoglycerate kinase (PGK), because of demonstrated higher
expression in undifferentiated and neural cell types, whereas the CMV promoter has
been known to be silenced in certain cell types [72, 73]. Therefore, the CMV pro-
moter was cut out, and replaced with the PGK promoter that was PCR-amplified
from the pLenti-PGK-GFP plasmid, graciously provided again by Dr. Scott Witting.
This PCR product was run out on a 1% low melting point agarose gel (Figure 2.4),
was purified using the Wizard Gel Purification Kit (Promega), and ligated to the
pGEM bacterial expression vector (Promega). JM109 bacterial cells (Promega) were
transformed with this construct per the manufacturer’s instruction and cells were
plated overnight on selective plates. The following day, single colonies were picked,
and grown for 16 hours at 37 ◦C. DNA was isolated from these bacterial cultures
using the QIAprep Spin Miniprep kit (Qiagen), and the PGK promoter was excised
using EcoRI and NheI cut sites at the 5′ and 3′ ends respectively. This product was
was separated from the pGEM backbone on a 1% low melting point agarose gel, was
further purified using the Wizard Gel Purification Kit (Promega) and an overnight
ligation reaction was used to insert it into the pCSCIGW backbone that had also been
gel-purified after being linearized using EcoRI and NheI (Figure 2.5). JM109 bacte-
rial cells (Promega) were transformed with this ligation product per manufacturer′s
instruction, and plated overnight on selective plates. The following day, ten single
colonies were picked, and grown for 16 hours at 37 ◦C. Plasmid DNA was isolated
from these bacterial cultures using the QIAprep Spin Miniprep kit (Qiagen). AscI
and MluI were initially used to confirm the PGK promoter insertion in these clones,
as there was one MluI recognition sequence on the pCSCIGW backbone, and the
PGK promoter itself had one novel AscI recognition site within its sequence. This
test identified 2 clones that yielded the two predicted fragments of 2716 bps and 7215
bps (Figure 2.6). The current sequence was confirmed by the Indiana University
DNA Sequencing Core Facility using custom sequencing primers (Figure 2.7). Due
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to the 5′ and 3′ long-terminal repeats (LTRs) on the lentiviral expression plasmid,
recombination-incompetent (mcrB mrr genotype) Stbl3 cells (Invitrogen) were used
for all subsequent transfections containing the lentivirus construct.
Figure 2.4. Agarose gel showing the PCR-amplified PGK promoter used
for ligation to pCSCIGW backbone
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Figure 2.5. The modified pCSC-PGK-IGW viral expression construct,
after the PGK promoter was inserted to replace the CMV promoter. This
construct was used for all gene insertion and expression experiments.
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Figure 2.6. Agarose gel showing clones 2 and 9 of the pCSC-PGK-IGW
ligation cut with MluI and AscI yielding the 2 expected products. Both
of these clones had the PGK-promoter correctly sequenced in full by the
Indiana University Core Facility using custom sequencing primers.
Figure 2.7. Custom sequencing primers used to sequence confirm the PGK
promoter in the pCSC-PGK-IGW backbone.
As the IRES-GFP sequence on the original pCSCIGW plasmid was not only unnec-
essary, but would interfere with the proposed screening system utilizing rhodopsin-
GFP reporter MEF cells, multiple cloning sites on the construct were used to intro-
duce genes of interest while simultaneously removing the IRES-EGFP segment of the
pCSC-PGK-IGW construct, including NheI, BmtI, AfeI, or AgeI 5′ to the insertion
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site, as well as BsrGI or XhoI 3′ to the IRES-EGFP sequence(Figure 2.5). This mod-
ified expression construct and multiple cloning sites were used for all gene expression
experiments.
2.4 Cloning strategies for the 23 gene candidate constructs
2.4.1 PCR amplification techniques
Initially, commercially-available gene constructs on bacterial plasmids were ordered
for all available genes to be used for PCR amplification, gel purification, and subse-
quent ligation to the lentiviral expression construct (Open Biosystems, Source Bio-
Science). Multiple cloning sites (MCSs) on both the 5′ and 3′ ends of the gene insertion
site enabled the construction of primer pairs designed with restriction enzyme recog-
nition sequences that were not present in the sequence of the gene of interest. Primers
for PCR amplification of genes were designed with restriction enzyme recognition se-
quences that were immediately followed by insertion of the first six bases of Kozak
sequence (GCCRCCAUGG) on the 5′ end, followed by complementary bases of the 5′
and 3′ gene sequence, respectively. The restriction enzyme recognition sequences were
added to enable the gene′s insertion into the lentiviral expression construct, while the
Kozak sequence (the six bases added in addition to the start codon of the gene) was
included to enhance the efficiency of translation of the gene product of interest after
delivery to somatic cells (Tables 2.3, 2.4).
PCR protocol modifications to obtain the correct gene sequences were necessary for
some genes included the addition of PCR enhancers, such as Betaine or DMSO, as
well as varying concentrations of template, polymerase, and magnesium chloride. Ad-
ditionally, PCR reactions were performed using a gradient of temperatures to identify
optimal conditions for each gene′s amplification. For example, PCR amplification us-
ing primers designed for Olig2 initially yielded no product of the right size (986 bps)
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visible on a 1% agarose gel. However, addition of 5% DMSO lead to a light band
of this size visible, and addition of 10% DMSO at 62.5 ◦C yielded the most specific
product (Figure 2.8). The original protocol and these modifications are covered in
detail in the methods chapter (CHAPTER 3).
Figure 2.8. PCR-amplification and optimization experiments for the Olig2
gene on an 1% agarose gel
Successfully PCR-amplified products were separated on a 1% low melting point
agarose gel alongside the pCSC-PGK-IGW vector that had been digested with cor-
responding restriction enzymes. These were gel-purified and ligated together. Stbl3
bacterial cells were transformed with this ligation product per the manufacturer′s
instruction, and plated overnight onto selective plates. The following day, single
colonies were picked, and grown for 16 hours at 37 ◦C. Plasmid DNA was isolated
from these bacterial cultures using the QIAprep Spin Miniprep kit (Qiagen). This
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DNA was test cut using the restriction enzymes with recognition sequences at the
5′ and 3′ ends, and run out on a 1% agarose gel. DNA isolated from clones that
had excision products corresponding to the expected size of the inserted genes were
sequenced by the Indiana University DNA Sequencing Core Facility.
While PCR protocol modifications lead to some additional genes being successfully
amplified and ultimately sequence-confirmed, many genes of interest were simply not
amenable to PCR amplification under any conditions tested, with or without protocol
modifications. All failures at PCR amplification were likely attributable to GC-rich
regions or templates of these particular genes.
Therefore, for several remaining gene sequences, a second strategy was utilized: genes
were cut out of the commercially provided bacterial expression construct with appro-
priate restriction enzymes, and ligated into a bacterial transfer vector, either the
pGEM (Promega), pLITMUS (New England Biosystems), or pCR2.1-TOPO system
(Invitrogen). This provided an additional method to add restriction enzyme recog-
nition sequences to the 5′ and 3′ ends of these genes that were compatible with the
modified pCSC-PGK-IGW lentiviral construct. Gene sequence compatibility with
available restriction sequences, as well as restriction sites on the original plasmids,
determined the system used for each remaining gene independently. Similar to PCR
amplification, this strategy was successful for several genes, but still, not all remaining
gene sequences were compatible with these systems.
2.4.2 Direct commercial custom gene synthesis
The final subset of genes of interest were either not at all commercially or academ-
ically available, or were unable to be synthesized/modified by any of the previous
strategies. Thus, these gene sequences were obtained through custom gene synthesis
approaches (Integrated DNA Technologies) that included insertion on a bacterial ex-
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pression vector. Such gene synthesis included sequence verification of both strands,
as well as plasmid mapping and generation of a FASTA sequence file. For the remain-
ing genes of interest, restriction enzyme sequences not contained within the gene but
within the multiple cloning sites of the lentiviral expression construct were added to
the 5′ and 3′ end of the gene sequence. These plasmids were expressed in chemically-
competent JM109 (Promega) cells, the DNA purified, and the gene of interest excised
by restriction digest. Successfully excised gene products were separated on a 1% low
melting point agarose gel alongside the modified pCSC-PGK-IGW vector that had
been digested with corresponding restriction enzymes. These were gel-purified and
ligated together. Stbl3 bacterial cells were transformed with this ligation product
per the manufacturers instructions, and plated overnight onto selective plates. The
following day, single colonies were picked, and grown for 16 hours at 37 ◦C. Plasmid
DNA was isolated from these bacterial cultures using the QIAprep Spin Miniprep kit
(Qiagen). This DNA was test cut using the restriction enzymes with recognition se-
quences at the 5′ and 3′ ends, and separated on a 1% agarose gel. DNA isolated from
clones that had excision products corresponding to the predicted size of the inserted
genes were sequenced by the Indiana University DNA Sequencing Core Facility.
2.5 Sequence-confirmation of lentiviral expression constructs
Prior to the use of lentiviral expression vectors containing candidate genes, it was
necessary to sequence verify the gene sequences to ensure proper transcription of
these transcription factors. Sequencing primers were thus designed approximately 100
basepairs up- and down-stream of the gene insertion site of the lentiviral construct
(Table 2.5). Each of the 23 gene constructs was sequenced-confirmed by sequencing
services provided by the Indiana University DNA Sequencing Core Facility. Most
sequence analyses confirmed approximately 500-800 base pairs in either direction, so
for several of the larger gene constructs, specific internal primers were designed to
confirm the entire internal sequence (Tables 2.6, 2.7). For each of 23 gene constructs,
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complete sequence confirmation was obtained for every nucleotide. The lone exception
to this was the Mybbp1a gene (4035 bps), which had been PCR-amplified and had
a single nucleotide base change at base 2804, an A to G substitution, resulting in
a change in amino acid at residue 1112, from lysine to arginine, maintaining the
positively charged residue at this amino acid.
Table 2.5
Custom sequencing primers for all gene insertions into the pCSC-PGK-
IGW expression plasmid
FORWARD 5′ AATAGCGGCTGCTCAGCA 3′
REVERSE 5′ GGCATTAAAGCAGCGTATCCAC 3′
2.6 Restriction enzyme-excision confirmation of large-scale plasmid DNA
Once each clone was sequence-confirmed, 100 mL cultures of bacteria expressing the
construct were grown overnight at 37 ◦C, and the plasmid was subsequently purified.
Each plasmid DNA sample was again confirmed by restriction enzyme excision of a
product of the genes corresponding size, from a backbone of approximately 9000 kbs,
to confirm that no contamination or mislabeling had taken place after plating from
glycerol stocks (Figure 2.9).
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Figure 2.9. Proper gene excision from the pCSC-PGK-IGW backbone.
Plasmid DNA was purified from 100 mL cultures after gene sequence
confirmation, cut with restriction enzymes, and imaged on a 1% agarose
gel.
2.7 Lentivirus production: protocol optimization
Lentivirus was chosen as the method of gene delivery due to the ability to yield a high
percentage of stable transformations. Expression vectors containing candidate genes
were transfected into HEK293 cells along with the third-generation viral packaging
plasmids VSVG, GAG-POL and REV and viral supernatant was collected 36 hours
later. Initial attempts at virus production yielded low-titer virus, as evidenced by low-
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infection coupled with minimal cell death in treated cultures of cells. Optimization of
the protocol included multiple changes to the initial method, including shortening the
incubation time, precise cell counts and quantifications for the amount of viral plas-
mids added to HEK293 cells, and lead to infection rates over 90%, as demonstrated by
EGFP-expression using a viral construct with the IRES-EGFP reporter intact for all
protocol optimization experiments (Figure 2.10). This optimized protocol is detailed
in the Methods Chapter.
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Figure 2.10. Optimization of the lentivirus production and delivery pro-
tocols yielded infection in over 90% of cells, as demonstrated by EGFP-
expression in HEK293 cells 60 hours after infection with the pCSC-PGK-
IGW construct with the IRES-EGFP reporter construct intact.
2.8 Demonstration of experimental feasibility and utility of constructs
To test the ability of candidate genes to be expressed in cells, and detected upon
analysis, expression vectors of these candidate genes were initially transfected into
HEK293 cells via calcium phosphate transfection. This protocol is detailed in Chap-
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ter 3, methods. Approximately 60 hours following transfection, samples were col-
lected for subsequent analysis. Commercially available antibodies exist for several of
the proteins of interest, and preliminary immunocytochemistry experiments demon-
strated upregulated protein expression when these constructs were delivered using
a calcium phosphate transfection system. Immunostaining for ASCL1, LHX2 and
OTX2 demonstrated upregulation of expression of each of these transcription factors
when delivered individually as compared to controls (Figure 2.11). The proper nu-
clear localization of these candidate transcription factors was observed in a majority
of cells after transfection. Induction of expression of these proteins thus demonstrated
the viability of these constructs for subsequent direct reprogramming applications.
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Figure 2.11. Upregulation of protein expression induced in HEK293 cells
via calcium phosphate delivery of pCSC-PGK-IGW gene constucts. (A)
ASCL1 (B) LHX2 and (C) OTX2 expression induced by construct deliv-
ery via calcium phosphate transfection to HEK293 cells, 60 hours post-
transfection.(D) CONTROL image. (D) Negative control representation
of no expression of ASCL1, LHX2 or OTX2 in untransfected cells via
immunostaining. All nuclei are DAPI-labeled (blue).
2.9 Reprogramming of somatic cells through delivery of transcription factors
Previous studies have demonstrated the feasibility of cellular reprogramming to a
neural lineage through the delivery of key transcription factors [18,22–26]. To demon-
strate the ability of the synthesized constructs containing transcription factors to lead
to neural reprogramming of MEF cells, the plasmids containing the transcription fac-
45
tors Ascl1 and Brn2 were delivered in combination to cultures of wild-type MEF
cells. The next day, the culture medium was changed and cells were maintained
for a total of 2 weeks with media changes every 2-3 days. After a total of 2 weeks
post-infection, cells were fixed with 4% paraformaldehyde and analyzed by immuno-
cytochemistry for the presence of neuronal phenotypes as a result of transcription
factor-based reprogramming. At this timepoint, numerous cells had adopted elabo-
rate neuronal morphologies, as well as the expression of the neuronal-specific protein
βIII-tubulin (Figure 2.12A). Uninfected control experiments lacked the expression of
βIII-tubulin.
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Figure 2.12. Downstream phenotypic and protein expression changes in-
duced in MEF cells after construct delivery (A) βIII-tubulin expression in
MEF cells, 2 weeks post-infection with a combination of Brn2 and Ascl1-
containing virus. (B) Ascl1 immunolabeling of cells in (A). (C) 60h post-
infection with the Olig2-containing construct, MEF cells derived from the
Rhodopsin-GFP fusion knock-in mouse were observed expressing GFP.
(D) Negative control representative no expression of Ascl1, Brn2 or Olig2
in untransfected cells via immunostaining. All nuclei are DAPI-labeled
(blue).
Given the ability to derive neuronal cell types through cellular reprogramming strate-
gies, it was then asked whether or not other transcription factors could lead to the
adoption of retinal photoreceptor-associated phenotypes. Using the previously identi-
fied candidate transcription factors described (Table 2.2), these genes were transfected
into MEF cells derived from the Rhodopsin-GFP fusion knock-in mouse. Within 60
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hours of following transfection, samples were collected for analysis via immunocy-
tochemistry to test for the upregulation of transcription factors as well as potential
morphological changes as a result of gene transfection. While most genes tested re-
sulted in the upregulation of gene expression within these MEF cells (Figure 2.12B),
it was observed that the introduction of the transcription factor Olig2 lead not only
to an increase in OLIG2 expression within these cells, but also to an apparent expres-
sion of green fluorescent protein, indicative of Rhodopsin-GFP expression throughout
the cytosol, presumably suggesting that OLIG2 may play an important role in the
activation of Rhodopsin expression (Figure 2.12C). This finding was exciting, as it
importantly demonstrated both the utility of the experimental design and system
utilized to identify candidate genes and demonstrated their effects on somatic cells,
as well as the ability of designed constructs to induce rhodopsin-promoter driven ex-
pression of GFP in MEF cells. Only several months ago, elegant clonal lineage studies
first identified Olig2 as a transcription factor expressed in a subset of retinal progeni-
tor cells from specific stages of development, producing daughter cells biased towards
amacrine cell interneurons and rod photoreceptors [30]. The current study described
herein utilizing cellular reprogramming strategies was undertaken a year and a half
before this finding was published, reinforcing the utility of choosing candidate genes
based initially on the rod-specific microarray datasets and then narrowed by the cri-
teria defined earlier in this thesis. As the remaining constructs are further tested and
characterized using the Rhodopsin-GFP knock-in MEF cells, more exciting findings
such as this stand to be discovered.
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3 DETAILED METHODS
3.1 MEF derivation
The protocol used to derive MEF cells from the Rhodopsin-GFP fusion knock-in mice
is from the website http://www.molgen.mpg.de [75]. Timed matings were set up, and
fetuses were harvested at approximately embryonic day 13.5 of gestation. Pregnant
female mice were euthanized with CO2, and cervically dislocated to ensure death. A
vertical superficial incision was made in the abdomen. The fetuses were dissected
from the uterus individually and put in a 10 cm dish of 1XPBS. One fetus at a time
was cut and washed in a new 10 cm plate of PBS. Each embryo was dissected out of
the amnion and placenta and put in its own 60 mm-dish of PBS. The embryo head
was dissected away to ensure that no retinal cells were included in MEF harverst.
The heart and liver were removed and discarded. The remaining tissue was washed
with 2 mL sterile 1X PBS and tissue was placed in a fresh 60mm dish. Tissue was
thoroughly minced with scapels and 2 ml of 0.25% trypsin with EDTA was added.
Tissue was incubated at 37 ◦C for 10 minutes and shook twice during this incubation.
After incubation, embryo tissue was vigorously pipetted up and down until it was a
single cell suspension (approximately 15 times). This 2 mL single cell suspension was
transferred to a 15 mL conical tube with 8 mL DMEM media with 10% FBS and
1% Penicillin/Streptomycin and pipetted up and down 5 times. Samples were left
for 5 minutes to ensure settling of non-dissociated tissue and then the supernatant
was transferred to a T-75 flask, and labeled ‘passage 1’. The next day the media was
changed. Cells were split every 3-4 days with 0.25% trypsin with EDTA at a ratio of
1:4.
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3.2 Cloning strategies
3.2.1 PCR amplification
Initial attempts at PCR cloning utilized primers with restriction enzyme recognition
sites added to the 5′ and 3′ ends (Tables 2.3, 2.4) and the Easy-A high-fidelity PCR
cloning kit (Agilent) with the manufacturers recommendations for reagent dilutions,
cycle lengths, and temperatures. Modifications to the protocol included: addition of
PCR enhancers including 1%, 5%, or 10% (DMSO) and/or 0.75 M Betaine (Sigma),
supplementation of 1-2.5 mM MgCl for final concentrations ranging from 3-4.5 mM,
addition of 5 amplification cycles, gradient PCR +/-4 ◦C in 1 ◦C steps, an increase
in primer concentration from 100 ng/µL to 250 ng/µL, and allowing an additional 1
minute for extension.
3.2.2 Serial bacterial expression vector cloning
Genes of interest were restriction enzyme excised from commercial suppliers bacte-
rial expression vectors, isolated using the Wizard gel-purification kit (Promega), and
ligated into the pGEM (Promega), pLITMUS (New England Biosystems) or pCR 2.1-
TOPO system (Invitrogen) using the Quick ligation kit (New England Biosystems).
Upon transformation of 5µL of ligation product into the JM109 (Promega) bacterial
strains per manufacturers instruction, cells were plated onto selective plates overnight.
The following day, single colonies were picked, and cultures were grown for 16 hours
at 37 ◦C. Plasmid DNA was subsequently purified using the QIAprep Spin Miniprep
kit (Qiagen). Genes of interest were re-excised with restriction enzymes that were
gene and viral vector compatible. These products, along with compatibly cut viral
vector backbone, were gel-purified, and ligated together using the quick ligation kit
(New England Biosystems) and Stbl3 cells (Invitrogen) were transformed. After plat-
ing overnight onto selective plates, single colonies were picked, cultures grown, DNA
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purified, and restriction enzyme test cut, samples were sent for sequencing to the
Indiana University DNA Sequencing Core Facility with custom sequencing primers.
3.2.3 Genes custom ordered from Integrated DNA Technologies
Lyophilized DNA was resuspended at 20 ng/µl in water, and 5µL was used to trans-
form JM109 bacterial cells (Promega). Genes were excised from the provided plasmid
using restriction enzyme sites that were engineered at the 5′ and 3′ ends. Compatibly
cut gene products and lentiviral expression vector were separated on a 1% low melt-
ing point agarose gel, isolated using The Wizard gel purification kit (Promega), and
ligated together using the quick ligation kit (New England Biosystems) and used to
transform Stbl3 bacterial cells (Invitrogen). Transformed cells were grown overnight
at 37 ◦C on LB/agar plates in the presence of carbenicillin. The next day, colonies
were picked, and added to 2 mL of LB containing carbenicillin (50µg/ml). Cultures
were grown overnight at 37 ◦C, and plasmid DNA was purified via the QIAprep Spin
Miniprep kit (Qiagen). Plasmids were then restriction enzyme test cut, and samples
were sent for sequencing to the Indiana University DNA Sequencing Core Facility
with custom sequencing primers (Table 2.6, 2.7).
3.3 Cell culture
HEK293 or MEF cells were plated in T75 flasks or onto poly-ornithine/laminin-coated
coverslips and allowed to grow overnight. Cell culture media consisted of DMEM
supplemented with 10% fetal bovine serum, 1X sodium pyruvate, 1X MEM non-
essential amino acids, and 1X penicillin/streptomycin. The following day, media was
changed and cells were monitored until they reached confluency. At confluency, cells
were passaged with 0.25% trypsin with EDTA and split at a ratio of 1:4.
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3.4 Virus production
HEK293 cells were plated at 5x106 cells per T75 flask. An excel spreadsheet (pro-
vided by Dr. Scott Witting of Indiana University School of Medicine) was used for
molar calculations for all plasmids. At the end of the next day, transfer plasmid,
packaging plasmids, CaCl2 solution and water, were added to one 5 mL cryovial and
labeled ‘DNA Master mix’. 2X HBSS was added to another 5mL cryovial. 12 mL
of fresh media was added to the HEK293 cells. A vortex in the BSC was set to 4.5,
and the vial of HBSS was continually vortexed. Using a P1000, the DNA master mix
was added dropwise, but fairly quickly, to the vortexing mix. A 1 minute timer was
started immediately after adding all the DNA master mix and this solution was incu-
bated in the hood for exactly 1 minute. As complex size increases rapidly over time,
any deviation from this 1 minute incubation will decrease the efficiency of delivery to
cells. The DNA/HBSS mix was added to the HEK293 cell flask. The flask was tilted
and calcium phosphate/DNA master mix was added dropwise on top of the media.
The solution was mixed well by tilting back and forth and turning the flask before
moving onto the next set. Flasks were placed back in the incubator overnight. The
following morning, media was removed and replaced with 12 mLs of HEK293 cell me-
dia. transfected cells were allowed to grow for another 35 hours and the supernatant
was collected. Media was filtered through a .45µm filter while in the BSC and twelve
1mL aliquots were made. 1-500µL was used to infect MEF or HEK293 cells for ini-
tial titration experiments to empirically determine the concentrations necessary for
each expression construct that yielded over 90% infection. For most expression con-
structs used in the experiments described, 50µL was sufficient, though MOIs remain
undetermined at the time of writing this thesis.
3.5 Calcium phosphate transfection
For each 10 cm dish, DNA was dissolved with 450µL water, 50µL of 2.5M CaCl2 and
mixed. This solution was slowly added dropwise into 500µL of BES, mixed thoroughly
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and incubated in the dark for 20 minutes. After, this solution was slowly dropped
into the culture dish, and distributed evenly by gentle rocking of the plate. Cells were
left to grow in the 37 ◦C/5% CO2 incubator for 12 hours. After 12 hours, media was
replaced. Cells were grown for approximately another 48 hours before being fixed for
the immunocytochemistry analysis described below.
3.6 Immunocytochemistry
Cells were fixed with 4% paraformaldehyde for ten minutes, washed three times with
PBS, and permeabilized with 0.2% Triton X-100 in PBS for 10 minutes. Samples were
blocked in PBS with 10% donkey serum for one hour to prevent non-specific antibody
binding. Primary antibodies were subsequently applied in 5% donkey serum/0.1%
Triton X-100 at recommended dilutions and incubated overnight at 4 ◦C. Following
three washes with PBS, fluorophore-conjugated secondary antibodies and DAPI were
applied at a 1:1000 dilution in 5% donkey serum/0.1% Triton X-100 for one hour at
room temperature. After 3 washes in PBS, coverslips were mounted on slides and
imaged on a Leica 5500 upright microscope with epifluorescence.
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4 CONCLUSIONS, FUTURE EXPERIMENTS AND IMPLICATIONS
4.1 Conclusions
This thesis undertook the design, establishment and characterization of a system
aimed to test the hypothesis that mouse embryonic fibroblasts, MEF cells, could be
genetically, directly reprogrammed to rod photoreceptors. Importantly, provision of
preliminary data in support of this hypothesis was also provided. The aims of this
study were sevenfold: to determine candidate genes for direct reprogramming stud-
ies, cloning of candidate genes into appropriate vectors, adapting a lentiviral system
for gene delivery, generating cells for use as a high-throughput screening system for
analysis of virally-infected or transfected somatic cells, provision of proof-of-principle
that the designed constructs led to induction of protein expression, collecting prelim-
inary data demonstrating the neuralization of somatic cells induced by combinatorial
delivery of known pro-neural genes and lastly, the induction of photoreceptor-like
phenotypes in somatic cells.
Each of these aims was addressed successfully. First, 23 candidate genes were iden-
tified and all 23 were successfully cloned or synthesized and inserted into a modified
lentiviral expression construct. The lentivirus production and delivery protocol was
modified to enhance induction of protein expression in over 90% of somatic cells in-
fected, as observed by using a GFP-reporter construct for optimization experiments.
MEF cells were derived from a mouse model with a Rhodopsin-GFP fusion knock-in
in place of native rhodopsin, enabling the high-throughput screening of the conver-
sion of these MEF cells using GFP-expression. As Rhodopsin expression is specific
to rod photoreceptors and one of the final stages of photoreceptor development, this
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is a reliable indication of MEF conversion to rod photoreceptor phenotypes. Anti-
bodies to the proteins produced by several constructs were commercially available,
and allowed for the demonstration of induction of protein expression when these con-
structs were delivered singularly or in combination to MEF cells. Preliminary data
demonstrated that the combinatorial delivery of constructs containing the pro-neural
genes Ascl1 and Brn2 led to the recapitulation of published work [18] demonstrating
expression of the neural-specific protein, βIII-tubulin. And lastly, utilizing the MEF
cells derived from Rhodopsin-GFP-fusion knock-in mouse, delivery of Olig2 alone
was demonstrated to induce expression of GFP, indicating its ability to activate the
rhodopsin promoter. While each of these aims was addressed, work remains to be
done to completely characterize and test the systems established. Furthermore, while
proof-of-principle was the aim and evidence was provided or exciting experiments
aimed at optimizing the direct reprogramming of fibroblasts to rod photoreceptor
have barely begun.
4.2 Future experiments continuing the project presented herein
The bulk of the work contained herein aimed to establish and confirm the tools
necessary to test the hypothesis that mouse embryonic fibroblasts could be directly
reprogrammed to rod photoreceptors. Previous studies described and the data pre-
sented establish the proof-of-principle that the direct reprogramming of photorecep-
tors is feasible using the constructs and systems established herein, although future
experiments will be necessary to confirm and expand upon these results, as well as
further optimize the system. To aid in these efforts, all 23 genes of interest have been
sequence-confirmed in the modified pCSC-PGK-IGW lentiviral expression construct,
and micro- to milligram quantities of each of these constructs have been restriction
enzyme excision-confirmed and are aliquoted and logged in long-term storage. Fur-
thermore, for many of these constructs, viral supernatants are also aliquoted and
stored. These tools will serve as the basis for many subsequent experiments, as well
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as used for further characterization studies. Preliminary data has demonstrated the
utility of these constructs generally, but each one still needs careful, individual char-
acterization. In order to achieve the highest efficiency of infection and presumably
greatest degree of reprogramming, viral supernatant titers need to be defined, cel-
lular toxicity determined, and multiplicities of infection (MOIs) established once a
qPCR-based analysis system is optimized. While preliminary data demonstrates up-
regulation of protein expression for all constructs tested, either delivered via calcium
phosphate transfection, or using the viral supernatants, this preliminary proof-of-
principle will have to be demonstrated and characterized for all remaining constructs
at both the mRNA and protein levels.
The most exciting data from this project is yet to come, as combinatorial delivery
of the constructs is largely untested at this time. Combinatorial testing of candi-
date transcription factors allows for the establishment of the optimal set of genes
for reprogramming, yielding the highest efficiency, while eliminating those that are
unnecessary and perhaps even inhibitory. Several strategies have been outlined and
developed to begin this process, utilizing the rod-specific, Rhodopsin-promoter-driven
GFP-reporter MEF cells. The systems to be tested, roughly in this order, include:
using a complete pool of all 23 factors, a system testing each factor in combination
with the pro-neural factor Ascl1, a system delivering Brn2, Ascl1, Myt1 (BAM)+ one
other factor at a time, one testing the effects of Ascl1+ the top candidates identified
from both +1 systems, and finally one testing the effects of removing each candidate
one at a time from the combination of top candidates. Each of these strategies can be
processed in a high-throughput screening scenario using the Rhodopsin-GFP MEF
cells generated. This experimental design should result in defining a minimum pool
for the direct reprogramming of MEF cells to a rod photoreceptor phenotype.
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4.3 Implications of work resulting in directly reprogrammed rod photoreceptors
The definition of a minimum pool of transcription factors that can directly repro-
gram somatic cells to a rod photoreceptor fate has staggering implications. Firstly,
it would be the first demonstration of direct reprogramming of somatic cells to a
sensory neuronal cell type. It would also provide researchers a system in which to de-
termine and characterize the earliest events in photoreceptor development, including
necessary and sufficient gene expression levels, which despite great efforts, continue
to evade characterization in the most well-designed systems and experiments to date.
It may uncover genes currently not known to be involved in the process of photore-
ceptor development. Furthermore, it would provide a much faster strategy to derive
and develop photoreceptors in vitro, which would be patient-specific, thereby rapidly
increasing opportunities leading to the development of therapeutic agents. For ex-
ample, photoreceptors reprogrammed from somatic fibroblasts could be utilized for
cell replacement for degenerative disorders such as macular degeneration or retinitis
pigmentosa. Additionally, when derived from patients with known genetic diseases
of the retina, these cells could be used as a novel platform for disease modeling and
pharmacological screening, particularly to study the pathology of a disease over time.
Furthermore, this system will allow for the design of experiments to test cellular
interactions of healthy and diseased cells, as well as interactions with cell types of
neighboring and surrounding tissue in co-culture systems, as well as characterization
of reprogrammed cells abilities to secrete survival factors and rescue diseased cells.
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